Case Studies

When approached with an ADA assay rescue project that had failed at two prior CROs, the BioAgilytix team knew scientific ingenuity would be needed. See how we applied a novel approach to overcome target interference challenges on a tight deadline, and got the study back on track. Read More

A case study on the development of a cell-based assay for the detection of neutralizing antibodies to determine patient eligibility to enroll in clinical trials for an AAV gene therapy. Read More

In this study, BioAgilytix had to assess the immunogenicity of the PEGlayted therapeutic with an approach that could maximize drug tolerance while maintaining high sensitivity. Read More

A top-five pharmaceutical company needed several angiogenesis biomarkers analyzed to support multiple Phase I clinical oncology studies. Read More

While conducting the pre-validation stage of a pharmacokinetic assay study, a sponsor asked BioAgilytix to develop a method for analyzing a specific therapeutic antibody when the results generated by another lab were not consistent with what was expected. Read More